An unresectable malignant perivascular epithelioid cell tumor resistant to multiple combined chemotherapies: A unique case report

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 4, 2010, Pages e136-e138

  Peng, Junjie ^a   Yu, Baohua ^a   Wang, Jian ^a   Hong, Xiaonan ^a   Xu, Ye ^a   Cai, Sanjun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Chemotherapy; Hmb45; Pecoma; Perivascular epithelioid cell tumor; Thalidomide

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CHINESE DRUG; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; MESNA; NEDAPLATIN; OXALIPLATIN; THALIDOMIDE;

ADOLESCENT; ARTICLE; CASE REPORT; FATALITY; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PERIVASCULAR EPITHELIOID CELL TUMOR; TREATMENT OUTCOME; ABDOMINAL BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CAUSE OF DEATH; INOPERABLE CANCER; PRIORITY JOURNAL; RARE DISEASE;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FATAL OUTCOME; HUMANS; MALE; PERIVASCULAR EPITHELIOID CELL NEOPLASMS; TREATMENT OUTCOME;

EID: 77952759872     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181b8700b     Document Type: Article

References (13)

1. Bonetti F, Pea M, Martignoni G, et al. PEC and sugar. Am J Surg Pathol. 1992; 16: 307-308.
2. Hornick JL, Fletcher CD. PEComa: what do we know so far? Histopathology. 2006; 48: 75-82.
3. Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol. 1998; 15: 21-40.
4. Folpe A, Mentzel T, Lehr H, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005; 29: 1558-1575.
5. Bonetti F, Martignoni G, Colato C, et al. Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis. Mod Pathol. 2001; 14: 563-568.
6. Greene LA, Mount SL, Schned AR, et al. Recurrent perivascular epithelioid cell tumor of the uterus (PEComa): an immunohistochemical study and review of the literature. Gynecol Oncol. 2003; 90: 677-681.
7. Agaimy A, Wunsch PH. Perivascular epithelioid cell sarcoma (malignant PEComa) of the ileum. Pathol Res Pract. 2006; 202: 37-41.
8. Jeon IS, Lee SM. Multimodal treatment using surgery, radiotherapy, and chemotherapy in a patient with a perivascular epithelioid cell tumor of the uterus. J Pediatr Hematol Oncol. 2005; 27: 681-684.
9. Parfitt JR, Bella AJ, Wehrli BM, et al. Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report. BMC Urol. 2006; 6: 20.
10. Rigby H, Yu W, Schmidt MH, et al. Lack of response of a metastatic renal perivascular epithelial cell tumor (PEComa) to successive courses of DTIC based-therapy and imatinib mesylate. Pediatr Blood Cancer. 2005; 45: 202-206.
11. Kenerson H, Folpe AL, Takayama TK, et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol. 2007; 38: 1361-1371.
12. Pan CC, Chung MY, Ng KF, et al. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol. 2008; 214: 387-393.
13. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008; 358: 140-151.